“The broader vision and mission of our study is to develop a minimally invasive blood test kit for early diagnostics, monitoring, and guiding therapeutic planning of triple-negative breast cancer patients.”
New Data Show ClearNote Health's Epigenomic Platform Provides a Novel Tissue-Free, Liquid Biopsy-Based Approach to Identify Potential Predictive Biomarker Candidates to Radioligand Therapy Response in Patients With Pancreatic Neuroendocrine Tumors
Med School Watercooler: 2023
Med School Watercooler: 2023
Identification of biomarkers associated with drug response using a
Ajay P. Singh, Ph.D.
Breast Cancer Research Foundation of Alabama (@BCRFAlabama) / X
The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors, Journal of Nanobiotechnology
Utilizing breath biopsy technology to detect disease early
Frontiers Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
Cancer Screening Research Network (CSRN)